Description
Using real-world data, the goals of this project are to understand the impacts of COVID-19 on (1) cancer care management, including detection, diagnosis and treatment of cancer, (2) patient-reported experience, and (3) costs of cancer care.
Specific Aims are:
Aim 1: Examine how cancer care is delivered in the ongoing COVID period. We will examine the patterns of care (telemedicine use and care disruption/recovery) over time following California’s shelter-in-place order and the subphases in the ongoing COVID period, and by patient characteristics (age, sex, race/ethnicity, language, cancer type, comorbidity, socioeconomic status).
Aim 2: Understand the impact of COVID-19 on patient experiences with and preferences for care. We will compare patient experience with care across patient groups: (a) between pre-COVID and ongoing COVID periods, and (b) between in-person visits and telemedicine visits.
Aim 3: Assess the economic impacts of COVID-19 in cancer care management. We will examine whether the distribution of cancer stage at diagnosis is shifted in the ongoing COVID period, with potential delay in care. We will compare subsequent costs of care between the two periods.
With Monique de Bruin, M.D., MPH, as physician lead, John K. Chan, M.D., Natalia Colocci, M.D., Ph.D., and Allison W. Kurian M.D., MSc, serve as physician advisors.
Principal Investigator
Co-Investigator(s)
Monique de Bruin, M.D., MPH, Cheryl Stults, Ph.D.
Funder
UC Office of the President, Research Grants Program Office
Start Date
November 01, 2020
End Date
October 31, 2021
Related Studies
COVID-19 Universal Registry for Vital Evaluations (CURVE) Project
Investigators: Robert Romanelli, Ph.D., MPH, Jiang Li, Ph.D., MPH
Impact of COVID-19 on Cancer Care Management
Investigators: Monique de Bruin, M.D., MPH, Su-Ying Liang, Ph.D.
Improving Cancer Care
Investigators: Su-Ying Liang, Ph.D., Harold (Hal) Luft, Ph.D., Ellis C. Dillon, Ph.D.
Pilot Project in Applied Artificial Intelligence: Using Machine Learning to Improve the Safety of Hospital Care
Investigators: Sylvia Sudat, PhD, Alice R. Pressman, Ph.D., M.S.
Quantifying 2D and 3D MRI Imaging For Improving MS Diagnosis, Treatment, And Clinical Care
Investigators: J.B. Jones, PhD, MBA, Xiaowei (Sherry) Yan, PhD, MS
Randomized study of EHR Defaults and Using social Comparison feedback to effectively decrease opioid prescription pill burden (REDUCE).
Investigator: Xiaowei (Sherry) Yan, PhD, MS
Statin Use and Risk Prediction of Atherosclerotic Cardiovascular Disease in Minority Subgroups (SURPASS) Study
Investigators: Jiang Li, Ph.D., MPH, External PI, Principal Investigator
Stupski Serious Illness Program Evaluation
Investigators: Sylvia Sudat, PhD, Ellis C. Dillon, Ph.D.
The Impact of Smoking, Comorbidities, and Race/Ethnicity on COVID-19 Infection and Disease Severity
Investigator: Jiang Li, Ph.D., MPH
Using Mobile Technology and Analytics to Track Outcomes in MS Patients
Investigators: Xiaowei (Sherry) Yan, PhD, MS, J.B. Jones, PhD, MBA